132 related articles for article (PubMed ID: 1723225)
1. NG-monomethyl-L-arginine increases platelet deposition on damaged endothelium in vivo. A scanning electron microscopic study.
Herbaczyńska-Cedro K; Lembowicz K; Pytel B
Thromb Res; 1991 Oct; 64(1):1-9. PubMed ID: 1723225
[TBL] [Abstract][Full Text] [Related]
2. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide.
Radomski MW; Vallance P; Whitley G; Foxwell N; Moncada S
Cardiovasc Res; 1993 Jul; 27(7):1380-2. PubMed ID: 7504587
[TBL] [Abstract][Full Text] [Related]
3. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.
Rees DD; Palmer RM; Schulz R; Hodson HF; Moncada S
Br J Pharmacol; 1990 Nov; 101(3):746-52. PubMed ID: 1706208
[TBL] [Abstract][Full Text] [Related]
4. Effect of nitric oxide synthase inhibition on bleeding time in humans.
Simon DI; Stamler JS; Loh E; Loscalzo J; Francis SA; Creager MA
J Cardiovasc Pharmacol; 1995 Aug; 26(2):339-42. PubMed ID: 7475061
[TBL] [Abstract][Full Text] [Related]
5. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.
Yao SK; Ober JC; Krishnaswami A; Ferguson JJ; Anderson HV; Golino P; Buja LM; Willerson JT
Circulation; 1992 Oct; 86(4):1302-9. PubMed ID: 1394936
[TBL] [Abstract][Full Text] [Related]
6. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
Adeagbo AS; Triggle CR
Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions.
de Graaf JC; Banga JD; Moncada S; Palmer RM; de Groot PG; Sixma JJ
Circulation; 1992 Jun; 85(6):2284-90. PubMed ID: 1591842
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the L-arginine:nitric oxide pathway in human platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
Frew JD; Paisley K; Martin W
Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774
[TBL] [Abstract][Full Text] [Related]
10. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors.
Laszlo F; Whittle BJ; Moncada S
Br J Pharmacol; 1994 Apr; 111(4):1309-15. PubMed ID: 7518298
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-derived relaxing factor inhibits platelet adhesion to cultured porcine endocardial endothelium.
Siney L; Lewis MJ
Eur J Pharmacol; 1992 Dec; 229(2-3):223-6. PubMed ID: 1283374
[TBL] [Abstract][Full Text] [Related]
12. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
[TBL] [Abstract][Full Text] [Related]
13. Platelets increase the tone of quiescent rat aortic rings by release of serotonin and potentiate the subsequent contractile response to norepinephrine.
Yang BC; Mehta JL
J Cardiovasc Pharmacol; 1994 Mar; 23(3):387-94. PubMed ID: 7515981
[TBL] [Abstract][Full Text] [Related]
14. Effects of NG-substituted arginines on coronary vascular function after endotoxin.
Winn MJ; Vallet B; Asante NK; Curtis SE; Cain SM
J Appl Physiol (1985); 1993 Jul; 75(1):424-31. PubMed ID: 7690746
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.
MacAllister RJ; Fickling SA; Whitley GS; Vallance P
Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309
[TBL] [Abstract][Full Text] [Related]
16. Acute compensation to abrupt occlusion of rat femoral artery is prevented by NO synthase inhibitors.
Unthank JL; Nixon JC; Dalsing MC
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2523-30. PubMed ID: 7529001
[TBL] [Abstract][Full Text] [Related]
17. Reduction by NG-nitro-L-arginine of H2O2-induced endothelial cell injury.
Shimizu S; Nomoto M; Yamamoto T; Momose K
Br J Pharmacol; 1994 Oct; 113(2):564-8. PubMed ID: 7530574
[TBL] [Abstract][Full Text] [Related]
18. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
[TBL] [Abstract][Full Text] [Related]
19. The effect of methylmercury (CH3HgCl) on the production of endothelium-derived relaxing factor (EDRF) by cultured human umbilical vascular endothelial cells based on its anti-aggregatory effect on human platelets.
Ohno M; Kishimoto T; Tada M
Cell Biol Toxicol; 1995 Dec; 11(6):303-11. PubMed ID: 8788207
[TBL] [Abstract][Full Text] [Related]
20. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter.
Bogle RG; Moncada S; Pearson JD; Mann GE
Br J Pharmacol; 1992 Apr; 105(4):768-70. PubMed ID: 1380372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
